News

New BÜHLMANN CAST® Allergens available!

We are pleased to announce the new 9 BÜHLMANN CAST® Allergens that will reinforce our commitment in the allergy diagnosis. With this release we will strengthen our Hymenoptera venom portfolio with a new dedicated allergen for the European paper wasp, as well as we developed alpha-GAL, a highly standardized allergen to address the new recognized

Read more

IBDoc News from ECCO 2017

IBDoc® has now been on the market for over 2 years and it is transforming the way IBD patients manage their disease. IBDoc® is used by over a thousand patients in more than 15 countries and we now support 20 languages with Hebrew as the latest addition. BÜHLMANN as the only calprotectin company has been able

Read more

Neuroimmunology explained in one simple Flyer

Sensitive Screening for anti-neural antibodies is a key step to identify autoimmune peripheral neuropathies. The new Neuroimmunology flyer explains why BÜHLMANN GanglioCombiTM MAG ELISA is the most sensitive screening for anti-Ganglioside and -MAG antibodies in one single step and why anti-MAG antibody ELISA is the gold standard. Click here to get access to the new

Read more

The Value of Calprotectin in Inflammatory Bowel Disease Monitoring

Inflammatory Bowel Disease (IBD) is a chronic inflammatory disease of the gut, which presents with periods of inflammatory activity (flares) and quiescent phases (remission) as can be seen in many chronic diseases. IBD includes several different diseases; the two most important ones are Ulcerative Colitis (UC), with inflammation localized mostly in the colon, and Crohn’s Disease (CD)

Read more